肿瘤免疫检查点抑制剂不良反应的监测与处理策略研究进展(4)
[13] Antonia SJ，Villegas A，Daniel D，et al. Durvalumab after Chemoradiotherapy in Stage Ⅲ Non-Small-Cell Lung Cancer [J]. N Engl J Med，2017，377(20)：1919-1929.[14] Teulings HE，Limpens J，Jansen SN，et al. Vitiligo-like depigmentation in patients with stage Ⅲ-Ⅳ melanoma receiving immunotherapy and its association with survival：a systematic review and meta-analysis [J]. J Clin Oncol ......
您现在查看是摘要页，全文长 3406 字符。